Most Read Articles
4 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

2 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
4 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.

Hepatocellular carcinoma incidence high in patients with alcoholic cirrhosis

29 Nov 2018

Hepatocellular carcinoma (HCC) is relatively common in patients with alcoholic cirrhosis, reports a new study.

Researchers evaluated 652 patients (median age 58.4 years; 68 percent male) with biopsy-confirmed compensated alcoholic cirrhosis, in whom the incidence of HCC was monitored. Other study outcomes included overall survival, event-free survival, liver-related mortality and hepatic focal lesions.

Majority of the participants (67.6 percent; n=441) were completely abstinent from alcohol, with a median duration of withdrawal of 24.7 months. At baseline, 44 patients (6.7 percent) had benign focal liver lesions, which were determined to be nonhepatocellular in 23, and hepatocellular in 11.

Over a median follow-up duration of 29 months, 125 patients developed liver lesions. The resulting 1- and 2-year cumulative incidence estimates were 13.3 percent and 20.8 percent, respectively. Most of these lesions remained benign, with only 43 patients (6.6 percent) eventually being diagnosed with HCC.

Researchers calculated the incidence rate of HCC to be 2.9 per 100 patient-years. The 1- and 2-year cumulative incidence rates were 1.8 percent and 5.2 percent, respectively.

Overall, majority of participants (77 percent; n=33) fulfilled the Milan criteria, but only 56 percent (n=24) ever received first-line curative treatment, such as liver transplantation, surgical resection and percutaneous ablation. Other patients opted for second-line liver treatments such as embolization and radiotherapy.

Seventy-three deaths were recorded, yielding a 2-year survival rate of 93 percent. Liver disease (44 percent; n=27) and liver decompensation (n=19) were the most prominent causes of death.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

2 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
4 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.